We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHA icon
11226
PUT
Schwab U.S Small- Cap ETF
SCHA
$23.7B
$70.4K ﹤0.01%
3,400
+2,200
+183% +$48.3K
ECHO
11227
CALL
EchoStar
ECHO
$26.7B
$70.3K ﹤0.01%
4,200
-2,600
-38% -$49.1K
IRWD icon
11228
PUT
Ironwood Pharmaceuticals
IRWD
$712M
$70.3K ﹤0.01%
7,300
+4,300
+143% +$42.1K
RAIL icon
11229
CALL
FreightCar America
RAIL
$240M
$70.2K ﹤0.01%
26,300
+5,000
+23% +$14.3K
MGTX icon
11230
CALL
MeiraGTx Holdings
MGTX
$1.3B
$70.2K ﹤0.01%
14,300
+5,200
+57% +$31.6K
SDC
11231
PUT
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$70.2K ﹤0.01%
169,100
-87,200
-34% -$49.8K
SPHB icon
11232
CALL
Invesco S&P 500 High Beta ETF
SPHB
$957M
$70.1K ﹤0.01%
1,000
-7,800
-89% -$588K
EDZ icon
11233
PUT
Direxion Daily MSCI Emerging Markets Bear 3X ETF
EDZ
$18.6M
$70K ﹤0.01%
510
+460
+920% +$55.8K
RBA icon
11234
PUT
RB Global
RBA
$15.6B
$70K ﹤0.01%
1,120
+100
+10% +$6.16K
IHS icon
11235
CALL
IHS Holding
IHS
$2.82B
$69.9K ﹤0.01%
12,600
+8,100
+180% +$60K
TERN
11236
PUT
DELISTED
Terns Pharmaceuticals
TERN
$69.9K ﹤0.01%
13,900
-12,100
-47% -$76.8K
GAN
11237
DELISTED
GAN Ltd
GAN
$69.8K ﹤0.01%
60,196
+42,495
+240% +$66.8K
CNF
11238
CNFinance Holdings
CNF
$37.9M
$69.7K ﹤0.01%
+1,845
New +$59.3K
ATRA icon
11239
PUT
Atara Biotherapeutics
ATRA
$81.2M
$69.7K ﹤0.01%
1,884
+1,340
+246% +$59.6K
PWSC
11240
DELISTED
PowerSchool Holdings, Inc.
PWSC
$69.5K ﹤0.01%
3,067
-113,014
-97% -$2.48M
WLDN icon
11241
CALL
Willdan Group
WLDN
$1.32B
$69.5K ﹤0.01%
3,400
+1,300
+62% +$27.6K
WSR
11242
DELISTED
Whitestone REIT
WSR
$69.2K ﹤0.01%
7,183
+5,243
+270% +$52.2K
AEG icon
11243
CALL
Aegon
AEG
$14B
$69.1K ﹤0.01%
14,400
-8,800
-38% -$45.3K
INMB icon
11244
CALL
INmune Bio
INMB
$60.2M
$69.1K ﹤0.01%
10,100
-2,700
-21% -$22.4K
LNZA icon
11245
LanzaTech
LNZA
$83M
$68.9K ﹤0.01%
+148
New +$97.5K
ARIS
11246
PUT
DELISTED
Aris Water Solutions
ARIS
$68.9K ﹤0.01%
6,900
+100
+1% +$1.06K
FULC icon
11247
PUT
Fulcrum Therapeutics
FULC
$285M
$68.8K ﹤0.01%
15,500
+1,200
+8% +$5.25K
LILM
11248
PUT
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$68.8K ﹤0.01%
96,400
+62,400
+184% +$72.9K
FDMT icon
11249
PUT
4D Molecular Therapeutics
FDMT
$673M
$68.7K ﹤0.01%
5,400
-6,600
-55% -$110K
CONN
11250
CALL
DELISTED
Conn's Inc.
CONN
$68.7K ﹤0.01%
17,400
-7,200
-29% -$29.9K

Similar funds

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.